Liu, XinyangQin, ShukuiWang, ZhichaoXu, JianmingXiong, JianpingBai, YuxianWang, ZhehaiYang, YanSun, GuopingWang, LiweiZheng, LeizhenXu, NongCheng, YingGuo, WeijianYu, HaoLiu, TianshuLagiou, PagonaLi, Jin2018-02-262018Liu, X., S. Qin, Z. Wang, J. Xu, J. Xiong, Y. Bai, Z. Wang, et al. 2018. “Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study.” Journal of Hematology & Oncology 11 (1): 5. doi:10.1186/s13045-017-0545-5. http://dx.doi.org/10.1186/s13045-017-0545-5.http://nrs.harvard.edu/urn-3:HUL.InstRepos:34869029en-USCorrection to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort studyJournal Article2018-02-2610.1186/s13045-017-0545-5